“…Our group prioritizes impact, pragmatism, and external validity, after being in settings with patients, clinicians, organizational leaders, community members, and policymakers too many times to count where internal validity was prioritized at the expense of producing viable interventions to deploy in contexts where care is delivered. Our lens highlights the implications of a long tradition of overvaluing, through the investment in research, discovery oriented work that focuses earlier in the translational pipeline that has not historically centered or amplified the voices of minoritized communities and individuals with lived experience (Baumann & Cabassa, 2020; Buckley et al, 2022; Shelton, Adsul, Oh, et al, 2021). This prioritization has resulted in often nonviable interventions that are not feasible to implement outside of controlled and well-resourced settings or do not produce the same level of effective outcomes for real-world communities resulting in limited return on investment (Glasgow, 2008).…”